Home » News » Currently Reading:

Teladoc To Acquire Livongo for $18.5 Billion

August 5, 2020 News 4 Comments


Virtual care provider Teladoc Health will acquire chronic condition management app vendor Livongo in a deal that values the company $18.5 billion, the companies announced this morning.

The announcement characterized the transaction as a merger, but the deal is structured as an acquisition. The combined companies will operate under the Teladoc name, Teladoc CEO Jason Gorevic will continue in that role, and Teladoc’s board chair will also remain in that role.

The share price of both companies dropped sharply midday Wednesday following the announcement. Both have seen their shares run up by multiples so far in 2020.

The companies expect their combined revenue to reach $1.3 billion in 2020. Teladoc just reported Q2 revenue of $241 million, up 85% as virtual visits increased by 203%.

Neither company has ever booked a quarterly profit. Teladoc went public in 2015, Livongo in 2019.

HIStalk Featured Sponsors


Currently there are "4 comments" on this Article:

  1. No quarterly profit ever, and an 18.5 billion price tag… Is there that much waste reduction in the US healthcare non-system to account for such strange valuation?

  2. Mr. Tullman & Mr. Shapiro poised to cash out (again). As has been proven with Allscripts and now here, it’s easier to raise money for a startup than it is to actually run a company.

Founding Sponsors


Platinum Sponsors



















































Gold Sponsors













Reader Comments

  • Jim Beall: Whoops; sorry. Phase III trial......
  • Jim Beall: Re: the Janssen coronavirus vaccine phase IV trial. I don't know if this vaccine is the same one reported here (https:...
  • Robert D. Lafsky M.D.: "One of the most effective, scalable, and sustainable strategies is providing context-specific information to healthcare...
  • John: Note that MSFT announced Cloud for Healthcare in early summer allowing users to use it under beta. At that time there wa...
  • TH: If a person was assigned female at birth, transitioned to male in their 20s, and has since been on hormone therapy for 2...

Sponsor Quick Links